Pediatric Cancers

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.

Fewer cancer drugs were exempt from pediatric testing requirements after the Research to Accelerate Cures and Equity, or RACE, for Children Act went into effect in 2020, a study showed.

PHILADELPHIA — In this video, Michael Fisher, MD, highlights the sessions and presentations at the International Symposium on Pediatric Neuro-Oncology.

Gestational substance abuse appeared linked to certain cancers among children, according to study results published in Cancer Epidemiology, Biomarkers and Prevention.

Multifocal disease is not linked to a greater risk of recurrence or mortality for children and adolescents with papillary thyroid carcinoma, according to a study published in The Journal of Clinical Endocrinology & Metabolism.

In this edition, obesity linked to adverse outcomes among AYAs; pirtobrutinib produces high response rates; CDC study reveals overall increase in pediatric cancer incidence and more.

Overall incidence of pediatric cancer in the United States increased 0.5% annually on average between 2003 and 2019, according to a CDC study published in Journal of the National Cancer Institute.

In this edition, we bring you a deep dive on a collaboration that aims to accelerate better treatments for pediatric cancers.

Advances in pediatric cancer research and treatment over the past 50 years have led to dramatic improvements in survival outcomes for this vulnerable population.

The issue of racial inequity in health care is complex and multifactorial, and researchers have been working to isolate specific factors involved in these disparities.